The Celiac Disease Foundation today announced its Board of Directors re-appointments for 2024. The Board represents a diverse mix of professionals, patients, and caregivers who are deeply committed to advancing the Foundation’s mission of accelerating diagnosis, treatments, and a cure for celiac disease.
Continue ReadingThe Celiac Disease Foundation, the nation’s leading patient advocacy organization for celiac disease, today is proud to announce its newest Board of Directors appointee, Dan Gibbons, who joins the organization this month.
Continue ReadingThe Celiac Disease Foundation announces its newest appointee, William Thurston, to its Board of Directors.
Continue ReadingThe Celiac Disease Foundation announces its newest appointee, Casey Guber, to its Board of Directors.
Continue ReadingThe Celiac Disease Foundation, the nation’s leading disease advocacy organization for celiac disease, announces the appointment of officers to its Board of Directors.
Continue ReadingOn August 29, 2019, the Celiac Disease Foundation’s 7th Annual New York Golf Outing was held at the New York Country Club in New Hempstead, NY.
Continue ReadingLos Angeles, CA (January 20, 2017) – Celiac Disease Foundation, the nation’s leading voluntary health organization for celiac disease, announces the appointment of two officers to its Board of Directors. The…
Continue ReadingCeliac Disease Foundation (CDF), the nation’s leading voluntary health organization for celiac disease, announces the appointment of five new members to its Board of Directors for the 2015-2017 term. Joining…
Continue ReadingCeliac Disease Foundation, the nation’s leading voluntary health organization for celiac disease, announces the appointment of four new members of its Board of Directors for the 2015-2017 term. Joining the Board of Director are Emily Luxford, Jody Morris, Jordan Ramer, and Jim Watson.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...